Skip to main content
DexCom, Inc. logo

DexCom, Inc.

Strategic / Corporate Investor6340 Sequence Drive, United StatesSee on the mapdexcom.com

medtechdigital healthbiosensingdiabetes

Dexcom is a medical technology company that develops glucose biosensing and continuous glucose monitoring products. Its technology is used to manage diabetes and track glucose and related health patterns.

2
Portfolio companies on reccy
0
Hiring now
0
Open roles in the portfolio
Nov 2024
Latest portfolio round

Hiring now in the portfolio0

None of their companies on reccy has an open role right now. Browse all neurotech roles

Portfolio on reccy2

Their companies, round by round

  • ŌURAHelsinki, Finland; Oulu, Finland; San Francisco, CA; San Diego, CA

    Wearables

    • Jul 2026Series E
    • Jul 2026Corporate
    • Oct 2025Series E · $900M
    • Sep 2025Debt · $250M
    • Nov 2024Series D · $200MLed
    • Apr 2022Venture Round
  • EpitelSalt Lake City, Utah

    EEG and neural monitoring · Wearables

    • Jul 2026Series B · $26M
    • Aug 2025Grant (prize money) · $7.6M
    • Mar 2025Venture Round · $3.1M
    • Feb 2022Series A · $12.5MLed
    • Feb 2022Grant
    • Dec 2019Seed

Rounds marked Led list DexCom, Inc. as a lead investor; the rest are the company's other funding.

Recent rounds in the portfolio

Portfolio in the news